| Project/Area Number |
25860478
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Medical and hospital managemen
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
HAYASHI Aki 東京大学, 医学部附属病院, 助教 (00381632)
|
|---|
| Research Collaborator |
KADOWAKI Takashi
OHE Kazuhiko
NANGAKU Masaomi
WAKI Kayo
FUJITA Hideo
FUJIU Katsuhito
KIMURA Shigeko
TOMIZAWA Nobuko
Kodama Kazuyo
SHIBUTA Tomomi
LEE Hanae
KOBAYASHI Haruka
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 遠隔医療 / 糖尿病 / 生活習慣 / 自己管理支援 |
|---|
| Outline of Final Research Achievements |
Self-management is the key of diabetes therapy. We developed a real-time partially automated interactive system, DialBetics, to support self-management for diabetes patients. Our previous randomized control trial for type 2 diabetes patients who were not on insulin injections showed that hemoglobin A1c (HbA1c) of the group using DialBetics improved significantly. In this study, we developed DialBetics to a more patient-friendly version based on the original participants’ feedback about the previous version. A pilot study was conducted to assess the safety and usability for type 2 diabetes patients on insulin injections. Mean HbA1c and BMI significantly decreased after 1 month while the dose of insulin for each patient remains the same. None of the patients experienced hypoglycemia or other adverse events during the study period. We conclude that safety of DialBetics was shown and a promising result was provided about the usefulness by type 2 diabetes patients on insulin injections.
|
